Systemic sclerosis (scleroderma) trials in India

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

  Where

  Hyderabad, Kolkata, New Delhi, Pune

  Age

  5 years to 80 years

  People

  1,072 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07691970
• Phase 3Taking people
  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  Where

  Bangalore, Bhubaneswar, Gurugram, Hyderabad, Kochi, Maharashtra, New Delhi

  Age

  18 years and over

  People

  448 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT07497087 · EU 2025-523884-39-00